In summary, we cautiously conclude Rlip is a promising new target for aging, AD, and other tauopathies/neurological diseases that have shown the relevance of oxidative stress and mitochondrial dysfunction in the disease process. This evidence concerns the gene RALBP1 and nervous system disorder.